Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-12-19 5:15 pm Sale | 13D | ACLARIS THERAPEUTICS INC ACRS | Arkin Moshe | 1,967,082 4.75% | -716,158 (-26.69%) | View |
| 2019-11-21 4:48 pm Sale | 13D | ACLARIS THERAPEUTICS INC ACRS | Arkin Moshe | 2,683,240 6.48% | -636,510 (-19.17%) | View |
| 2019-10-15 5:00 pm Purchase | 13D | ACLARIS THERAPEUTICS INC ACRS | Arkin Moshe | 3,319,750 8.02% | 3,319,750 (New Position) | View |
| 2019-08-21 08:12 am Purchase | 13D | SOL-GEL TECHNOLOGIES LTD SHS SLGL | Arkin Moshe | 13,699,936 67.2% | 86,000 (+0.63%) | View |
| 2019-06-03 09:40 am Sale | 13D | UROGEN PHARMA LTD URGN | Arkin Moshe | 1,377,991 6.63% | -71,488 (-4.93%) | View |